In a story January 30, 2021, about the Novavax vaccine, The Associated Press erroneously reported that it has shown about 60% efficacy in HIV-positive patients
Sir Elton John s sadness at coronavirus death of his South African doctor friend
EXCLUSIVE: Singer is said to be “deeply upset” at the passing of children s HIV doctor who he became pals with after she wrote to the superstar asking for help in rebuilding a hospital
22:51, 23 JAN 2021
Updated
Dr Arthi’s treasured pic with Elton and Lindiwe, left
Never miss an update on schools, pubs and coronavirus cases with our free newsletterInvalid EmailSomething went wrong, please try again later.
Sign up!
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.
Sebastian Condrea via Getty Images
There are fundamental differences between HIV and SARS-CoV-2, the virus that causes COVID-19, that make developing a vaccine easier for one than for the other.
When Pfizer and BioNTech announced their astounding SARS-CoV-2 vaccine efficacy results in November, Arthur Reed was ecstatic.
“The global investment and coordination of billions of dollars enabling this unprecedented pace of scientific discovery is truly an incredible achievement,” he said.
But as a gay man in New York City living with HIV since the 1980s, he couldn’t help but wonder about the government and public response to SARS-CoV-2, the virus that causes COVID-19, compared to the early days of HIV/AIDS.